News and Announcements
Shivom & Spherity Work Together to Enhance DNA Data Storage & Privacy
- Published April 22, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Key Takeaways:
- Spherity has partnered with Shivom
- Spherity offers Shivom ideal programs for encrypting the ever-increasing DNA datasets that will be stored within the Shivom ecosystem
- The OmiX presale ends April 22nd, 2018
Spherity, a leader in creating applications that can interlink any entity with a unique identifier linked to a digital twin, has partnered with Shivom to lend increased levels of protection and ensure privacy of its massive DNA database.
Spherity will facilitate the 4th industrial revolution, bridging the gap between the physical, biological and digital, and provides interfaces that are easy to access, practical, and fully efficient to secure large databases by decentralizing digital twin applications and softwares. At Shivom, as we’re working to democratize DNA sequencing and storing genomic information using blockchain technology, and we are thrilled to partner with Spherity which offers an ideal solution and programs for encrypting the ever-increasing DNA datasets that will be stored within the Shivom ecosystem.
If the predictions related to DNA sequencing are to be considered, then by 2025 about 2 billion people would have had their DNAs sequenced. That’s a lot of private data, and with help and guidance from Spherity, we are prepared to tackle this challenge, who share our vision regarding the security of sensitive information.
Visit Spherity for more information about their programs and integrated solutions.
Remember you don’t want to miss your chance to participate in the OmiX token presale, register at https://tokensale.shivom.io/
The presale ends April 22nd, 2018.
About Shivom
Shivom combines blockchain, A.I., DNA sequencing & cryptography to enable secure and personalized medicine. The Shivom platform works on collaboration & integrity, allowing people to own, manage and monetize their data. By creating a web-marketplace, a network of genomic counsellors, and a not-for-profit drug research unit, Shivom will build a global healthcare ecosystem, reaching even low-income countries.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
